EQUISUL-SDT® is indicated for the treatment of lower respiratory tract infections in horses caused by susceptible strains of Streptococcus equi subsp. zooepidemicus. EQUISUL-SDT® is produced using Aurora Pharmaceutical’s patented drug product formulation. The product demonstrated 20% increased bioavailability over an existing paste product in a pharmacokinetic crossover study.
|16 oz. Bottle
|Reorder No: 19001
|Reorder No: 19002
Clicking a link on this page will open a PDF file in a new window.